Kura Oncology Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 0.55x

Kura Oncology Inc cash flow reinvestment rate. Kura Oncology Inc (KURA) has a Cash Flow Reinvestment Rate of 0.55x as of December 2025, reinvesting $64.60 Million (capex $2.32 Million plus investments $-62.27 Million) from operating cash flow of $117.27 Million. Explore Kura Oncology Inc (KURA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.55x

(Capex + Investments) / Operating CF

Total Reinvested

$64.60 Million

Capex + Investments

Operating Cash Flow

$117.27 Million

USD

Capital Expenditures

$2.32 Million

USD

Cash Flow Reinvestment Rate of Kura Oncology Inc (2024–2024)

Cash flow reinvestment rate of Kura Oncology Inc from 2024 to 2024. Historical reinvestment intensity for Kura Oncology Inc across 1 annual periods. Explore Kura Oncology Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Kura Oncology Inc Cash Flow Reinvestment Rate by Year (2024–2024)

Kura Oncology Inc cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Kura Oncology Inc. For the full cash flow conversion analysis, see cash flow conversion of Kura Oncology Inc.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2024	0.76x	$102.06 Million	$134.32 Million	$472.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow